Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price hits fresh 52-week high at Rs 1,952.45
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Share Price is in focus after the stock rose to Rs 1,952.45, up 0.36% today, and touched a fresh 52-week high of Rs 1,953.5. The company’s market capitalisation stands at Rs 1,00,943.83 crore, keeping Laurus Labs Ltd. (LAURUSLABS) among the most closely watched names in healthcare this morning. As of 09 September 2026 at 9:22 AM IST, the latest Univest data confirms the price event, while the available numbers do not establish a company-specific catalyst. Laurus Labs Share Price Today is therefore being tracked for the combination of a new yearly high, a modest intraday gain and a large market value.
For readers following Laurus Labs Stock News and Laurus Labs News Today, the important point is simple: the stock has moved to a fresh 52-week high without any verified event-based explanation in the numbers provided. That makes the move relevant for Laurus Labs Share Price Live monitoring, especially because the price is trading very close to the day’s high and the prevailing market capitalisation is above Rs 1 lakh crore.
Laurus Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,952.45 |
| Previous Close | Rs 1,945.5 |
| Today's Move | +Rs 6.95 (+0.36%) |
| Open | Rs 1,949.05 |
| High | Rs 1,953.5 |
| Low | Rs 1,941.5 |
| Turnover | Rs 1.11 crore |
| Market Capitalisation | Rs 1,00,943.83 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,952.45 versus the previous close of Rs 1,945.5, a rise of 0.36%. The stock opened at Rs 1,949.05, reached a high of Rs 1,953.5 and touched a low of Rs 1,941.5.
Laurus Labs Share Price Today was last traded at Rs 1,952.45 versus the previous close of Rs 1,945.5, a gain of Rs 6.95 or 0.36%. The stock opened at Rs 1,949.05, touched an intraday high of Rs 1,953.5 and a low of Rs 1,941.5, with turnover at Rs 1.11 crore. The day’s high is also the fresh 52-week high, so Laurus Labs Share Price is currently positioned at the upper end of the trading range seen so far today.
That price behaviour is enough to place Laurus Labs Share Price in the 52 Week High Stocks conversation on Stock Market Today and Share Market Today screens. The move is factually narrow in percentage terms, but it matters because the stock has set a new one-year high while remaining within a tight range around that level. For those tracking Laurus Labs Share Price Update or Laurus Labs Share Price News, the immediate question is whether the market continues to quote the stock near this yearly high through the rest of the morning.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,00,943.83 crore |
| P/E Ratio | 96.14x |
| P/B Ratio | 18.64x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 20.24 |
| Book Value Per Share | Rs 104.37 |
| Dividend Yield | 0.1% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 96.14x, P/B 18.64x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.
Laurus Labs Ltd. has a market capitalisation of Rs 100943.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 96.14x, P/B at 18.64x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.08x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 96.14x |
| Benchmark Median P/E | 32.08x |
| Benchmark Average P/E | 48.85x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | 18.64x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 1,00,943.83 crore |
| Benchmark Median Market Cap | Rs 704.3 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.14x, which is above the benchmark median of 32.08x, a difference of +199.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.81%, a difference of +55.04%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.68%, a difference of +33.04%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Lupin Ltd. | LUPIN | 96,254.46 | 17.47 | 4.06 | 27.11 | 28.86 |
| Mankind Pharma Ltd. | MANKIND | 95,911.14 | 46.63 | 5.66 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 95,570.85 | 29.83 | 2.52 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 95,397.65 | 26.13 | 2.49 | 9.93 | 12.76 |
| Cipla Ltd. | CIPLA | 1,12,773 | 33.17 | 3.18 | 11.83 | 16 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.14x compared with the displayed peer median of 29.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,00,943.83 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs Share Price hit a fresh 52-week high of Rs 1,953.5 during the current morning session.
- Laurus Labs Share Price Today is Rs 1,952.45, up Rs 6.95 or 0.36% from the previous close.
- Market capitalisation stands at Rs 1,00,943.83 crore, placing Laurus Labs in a large listed valuation band by market value alone.
- P/E is 96.14 and P/B is 18.64, both above the same-industry benchmark median.
- ROE is 18.31%, ROCE is 18.2%, EPS is Rs 20.24 and book value is Rs 104.37 per share.
About Laurus Labs
Laurus Labs Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. Laurus Labs Stock News typically follows the company through its listing on NSE and BSE, where Laurus Labs Share Price is tracked alongside other pharmaceutical names. The company’s latest financial numbers show revenue and profit updates through Jun 2026, and its market value places it among the larger listed names in the segment. For investors following Laurus Labs Company News, the latest one-year high keeps the stock visible in Indian Stock Market screens and sector reviews.
Frequently Asked Questions
Why is Laurus Labs Share Price in the news today?
Ans. Laurus Labs Share Price is in the news because it touched a fresh 52-week high of Rs 1,953.5 and was last traded at Rs 1,952.45, up 0.36% from the previous close.
What is the current Laurus Labs Share Price Today?
Ans. Laurus Labs Share Price Today is Rs 1,952.45. The stock opened at Rs 1,949.05, touched Rs 1,953.5 and traded near the day’s high as of 09 September 2026 at 9:22 AM IST.
What is the 52-week high for Laurus Labs Share Price?
Ans. Laurus Labs Share Price touched a fresh 52-week high of Rs 1,953.5 in morning trade. That level is also the day’s high, which keeps the stock in focus for one-year high searches.
How much is Laurus Labs market capitalisation?
Ans. Laurus Labs has a market capitalisation of Rs 1,00,943.83 crore. That market value is relevant for Laurus Labs Share Price analysis because it places the company among the larger listed names in its industry.
What valuation does Laurus Labs Share Price reflect?
Ans. Laurus Labs Share Price reflects a P/E of 96.14 and a P/B of 18.64. Both are above the same-industry medians of 32.08 and 3, which makes valuation a key part of the discussion.
How do Laurus Labs profitability ratios compare with the sector?
Ans. Laurus Labs reports ROE of 18.31% and ROCE of 18.2%, both above the industry medians of 11.81% and 13.68%. Those figures add context to Laurus Labs Share Price and sector comparison.
What do Laurus Labs EPS and book value show?
Ans. Laurus Labs EPS is Rs 20.24 and book value is Rs 104.37 per share. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share.
How should readers view Laurus Labs Share Price on Univest?
Ans. Readers can track Laurus Labs Share Price on Univest for live price updates, financial ratios, 52-week levels, financial results and peer comparison. It is a useful place to follow Laurus Labs Share Price Today and Laurus Labs Stock News.
Track Laurus Labs Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Laurus Labs Share Price on Univest for live updates, share price history, market cap, valuation ratios, financial results, 52-week levels and comparison with sector peers. Univest also helps you follow Laurus Labs Share Price Today, Laurus Labs Latest News and Laurus Labs Stock Analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
